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Overview of thesis projects, collaborations, and publications 
All steps, tasks and experiments necessary for planning, realization, completion, and 
publication of the projects, which all contribute to this thesis work were carried out by myself, 
unless stated otherwise in ‘contribution of coauthors or collaborators’ under each of the 
following projects. Felix Beuschlein, senior author in all publications, my mentor, and 
principle investigator of our study group is not mentioned separately, as he was closely 




Project 1: Identification and characterization of the adrenal side population 
 
Publication: The side population phenomenon enriches for designated adrenocortical 
progenitor cells in mice. Lichtenauer U, Shapiro I, Sackmann S, Drouin J, Scheele J, Maneck 
M, Klein C, Beuschlein F. J Endocrinol. 2012 Dec;215(3):383-91. doi: 10.1530/JOE-12-0393. 
Epub 2012 Oct 5 
 
Contribution of coauthors or collaborators: 
Jaques Droin: principal investigator, Montreal Canada, provided us with Tpit-Knockout 
animals, which we bred and used for the investigation of the role of ACTH in side population 
cells.  
Jürgen Scheele, principal investigator, Freiburg, provided us with Pbx1 haploinsufficent 
animals, which we bred and used to characterize the influence of Pbx1 haploinsufficiency on 
side population cells. 
Urs D. Lichtenauer  Adrenal progeny and factors of adrenal differentiation 
 
 
- 7 - 
Christoph Klein, principal investigator and Matthias Maneck, PhD student, Institut für 
Pathologie, Regensburg, carried out Microarray analyses on side population vs. non-side 
population cells, and helped us interpreting the data and provided us with the heatmap (Figure 
2A of original publication). His established platform is especially designed for small cell 
numbers.  
Simone Sackmann: graduate student, supported me with organ harvesting and intraperitoneal 
ACTH applications. 
Igor Shapiro, lab technician of our research group, took over most of the maintenance work 
such as tagging, tailing and genotyping of mice, passaging of cell culture cells and regular cell 
culture medium, exchange. He also supported me with the immunohistochemistry staining 
procedure. 
All coauthors contributed to their part of the Material & Method section, read the draft, made 
suggestions to improve the manuscript and proof-read the final version before submission. 
 
My contribution to this project: 
Except for the contributions of the collaborators listed above, the whole project was planned, 
carried out and published by myself under the supervision of my mentor Felix Beuschlein, as 
mentioned in the preceding introductory statement of the overview. In detail, the acquisition 
of the mice strains needed for our study as well as most of the breeding was organized by me 
including taking care of the licensing for animal testing. In addition, I also established the 
PCR genotyping assay that was required. I adapted the side population staining procedure for 
adrenal cells and it is now the standard protocol used by our laboratory. Thereafter, I carried 
out adrenal harvesting, preparation of adrenal single cell suspensions and staining procedures 
for all subsequent FACS and flow cytometric analysis. All of these staining duties were 
performed under my direct supervision while they were carried out by a technician of the 
Core Facility in Freiburg. Except for maintenance work, I performed all cell culture 
experiments including the production of cell culture photographs used in publication. With the 
support of our lab technician, Igor Shapiro, I also carried out all immunohistochemistry 
experiments used in publication as well. I established and managed the communication 
contacts required for the project with all the collaborators involved. All data, including data 
from collaborators, was collected, interpreted, as well as prepared for publication by me under 
the supervision of my principal investigator. I wrote all drafts of the manuscript, incorporating 
comments and corrections from all the coauthors involved, and was responsible for submitting 
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Project 2: Cell Fusion as a model to define pluripotent and committed adrenal 
progenitor cells 
 
Publication: not published 
 
Contribution of collaborators: 
Keith Parker, principal investigator, Jean D. Wilson Center for Biomedical Research, 
Southwestern University, Texas, USA, provided us with Sf1-Cre animals. 
Hans Jörg Fehling, principle investigator, Institut für Immunologie, Universitätsklinikum 
Ulm, provided us with tdRFP reporter mice. 
Martin Zenke, principle Investigator, Institut für Biomedizinische Technologien, RWTH 
Aachen, provided us with Oct4-GFP animals. 
Michele Boiani, PostDoc, Max Planck Institute for Developmental Biology in Münster, 
helped us during a short research stay with SF1-tdRFP blastocyst generation to establish a 
primary embryonic stem cell culture. Michele Boiani also started the embryonic body 
cultures. 
Igor Shapiro, lab technician of our research group, was involved in mouse breeding and 
maintenance work including tagging and tailing, embryonic cell culture (medium change, 
feeder cell preparations, passaging of ES cells). 
 
My contribution to this project: 
Except for the contributions of the collaborators listed above, the whole project was planned, 
carried out by myself under the supervision of my mentor Felix Beuschlein, as mentioned in 
the preceding introductory statement of the overview. In detail, the acquisition of the mice 
strains needed for our study as well as most of the breeding was organized by me including 
taking care of the licensing for animal testing. In addition, I also established the PCR 
genotyping assay that was required. I established embryonic stem cell line cultures and feeder 
cell preparations in our laboratory. I initiated the collaboration with the Max Planck Institute 
(MPI) for Developmental Biology and organized short research visits to Münster, where the 
embryonic primary SF1-tdRFP cell line was established together with Michele Bojani from 
the MPI. I had to harvest murine adrenal glands for this project, in order to obtain adrenal 
single cell suspensions for the fusion experiments, which I carried out with the support of our 
lab technician, Igor Shapiro. I designed and processed all real-time PCR experiments of this 
project. I established and managed the communication contacts required for the project with 
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all the collaborators involved. All data, including data from collaborators, was collected and 
interpreted by me under the supervision of my principal investigator. This project was 
supported by a LMU FOEFOLE grant, for which I successfully applied. In consequence, I had 
to manage the associated administrative tasks as the responsible investigator. 
 
 
Project 3: Defining regulators of adrenal organogenesis and steroidogenesis 
 
Publication: Lichtenauer UD, Duchniewicz M, Kolanczyk M, Hoeflich A, Hahner S, Else T, 
Bicknell AB, Zemojtel T, Stallings NR, Schulte DM, Kamps MP, Hammer GD, Scheele JS, 
Beuschlein F. Pre-B-cell transcription factor 1 and steroidogenic factor 1 synergistically 
regulate adrenocortical growth and steroidogenesis. Endocrinology. 2007 Feb;148(2):693-
704. Epub 2006 Nov 2. 
 
Contribution of coauthors or collaborators: 
Mark Kamps, principle investigator, Department of Pathology (M.P.K.), University of 
California San Diego, School of Medicine, La Jolla, California, initiated the project of 
generating Pbx1 haploinsufficient animals (Figure 1A of the original publication). 
Jürgen Scheele, principal investigator, Department of Internal Medicine, Universitätsklinikum 
Freiburg, originally generated Pbx1 haploinsufficient animals together with Thomas Zemojtel 
and Matteusz Kolanczyk, PostDocs and provided us with Pbx1 animals (Figure 1B – D) 
Dominik Schulte, graduate student of our research group, started breeding Pbx1 animals in 
our facility and found evidence for smaller adrenal glands in Pbx1 haploinsufficient animals 
compared to wild type mice in preliminary experiments, before he left our research group. 
Stephanie Hahner, endocrine fellow, Department of Medicine, Uniklinik Würzburg, carried 
out the hormonal measurements in mouse serum. 
Andrew Bicknell, principal investigator, School of Animal and Microbial Sciences, 
University of Reading, Reading, United Kingdom, carried out the Hox in-situ hybridization 
experiment (Figure 2 of the original publication). 
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Andreas Höflich, principal investigator, Genzentrum, LMU München, performed the realtime 
PCR analyses of IgF1, IgF binding protein 1 and IgF1-receptor (Figure 4E of original Pbx1 
publication). 
Gary Hammer, principal investigator and Tobias Else, PostDoc, Department of Internal 
Medicine, Ann Arbor, Michigan, USA, carried out Pbx1 und Sf1 immunoprecipitation (Figure 
6E of original Pbx1 publication). 
Nancy Stallings, graduate student, Department of Internal Medicine, University of Texan, 
Southwestern, Texas, USA, provided us with a Sf1 artificial promotor. 
All coauthors contributed to their part of the Material & Method section, read the draft, made 
suggestions to improve the manuscript, and proof-read the final version before submission. 
 
My contribution to this project: 
Except for the contributions of the collaborators listed above, the whole project was planned, 
carried out and published by myself under the supervision of my mentor Felix Beuschlein, as 
mentioned in the preceding introductory statement of the overview. In detail, the acquisition 
of the mice strains needed for our study as well as most of the breeding was organized by me 
including taking care of the licensing for animal testing. In addition, I also established the 
PCR genotyping assay that was required. I carried out adrenal gland harvesting and 
measuring, paraffin embedding, DNA, RNA, Protein extraction, cDNA synthesis, and blood 
collections. I performed the hormone stimulatory and restrain stress experiments and carried 
out the immunohistochemistry and, immunoblotting, used in the publication. I established and 
managed the communication contacts required for the project with all the collaborators 
involved. All data, including data from collaborators, was collected and interpreted by me 
under the supervision of my principal investigator. I wrote the manuscript draft, kept in 
contact with the coauthors, and carried out corrections, before the final draft was submitted. 
 
 
Project 4: Defining the role of side population cells in adrenocortical carcinomas 
 
Publication: Lichtenauer UD, Shapiro I, Geiger K, Quinkler M, Fassnacht M, Nitschke R, 
Rückauer KD, Beuschlein F. Side population does not define stem cell-like cancer cells in the 
adrenocortical carcinoma cell line NCI h295R. Endocrinology. 2008 Mar;149(3):1314-22. 
Epub 2007 Dec 6. 
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Contribution of coauthors or collaborators: 
Klaus Rückauer, attending, Department of Neurosurgery, Universitätsklinik Freiburg, Martin 
Fassnacht, fellow, Medizinische Klinik Würzburg, and M. Quinkler, fellow, Medizinishce 
Klinik, Charité, Berlin provided us with human adrenal tissues for our studies. 
Technical on-site support was provided by Klaus Geiger, lab technician, Core Facility, 
Universitätsklinikum Freiburg, for FACS experiments, and by Roland Nitschke, biologist and 
head of the Life Imaging Center, Universität Freiburg for laser confocal microscopy. 
Dirk Engelbert, graduate Student, Department of Internal Medicine, Universitätsklinikum 
Freiburg, helped us with the FACS analysis and data interpretation of the cell cycle study. 
Igor Shapiro, lab technician of our research group, was involved in cell culture maintenance 
work, helped to establish adrenal primary cultures and was involved in the side population 
staining procedure. 
All coauthors contributed to their part of the Material & Method section, read the draft, made 
suggestions to improve the manuscript, and proof-read the final version before submission. 
 
My contributions to this project: 
Except for the contributions of the collaborators listed above, the whole project was planned, 
carried out and published by myself under the supervision of my mentor Felix Beuschlein, as 
mentioned in the preceding introductory statement of the overview. In detail, I adapted the 
side population staining procedure to human and mice cancer cells, e.g. by employing 
confocal microscopy time course experiments, I prepared adrenal single cell suspensions from 
human adrenal tumor entities. Later, I prepared and supervised all FACS and cytometric 
investigations and performed all cell culture experiments with the cell line NCI-h295R 
including chemotherapy treatments and proliferation assays. I performed all real-time PCR 
analyses and produced all photographs used in publication. I established and managed the 
communication contacts required for the project with all the collaborators involved. All data, 
including data from collaborators, was collected, interpreted, as well as prepared for 
publication by me under the supervision of my principal investigator. I wrote all drafts of the 
manuscript, incorporating comments and corrections from all the coauthors involved, and was 
responsible for submitting the final version of the manuscript as well as handling all revisions 
and aspects of the rebuttal process.  
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Abstract 
Radioactive and transgenic tracing experiments indicate that the adult adrenal cortex is 
maintained by a common pool of stem cells, which reside in the periphery of the adrenal 
cortex in the subcapsular zone. For repopulation, adrenal progenitor cells migrate towards the 
organ center, where they differentiate within the different specialized adrenocortical zones 
and take over specific adrenocortical functions. However, isolation and detailed investigation 
of adrenal progenitor cells has been hampered by the lack of known marker genes. There is 
convincing data that utilizing the side population, which is based on Hoechst 33342 dye 
exclusion, leads to an enrichment of progenitor or stem cells in the hematopoietic system and 
multiple other tissues. In the absence of known stem cell marker genes, we employed the side 
population technique on adrenal cells. In contrast to non-side population cells, side population 
cells readily grew over several passages in vitro. Furthermore, after 4 weeks in culture, 
immunohistochemistry revealed steroidogenic enzyme expression, suggesting spontaneous 
differentiation. Microarray analysis was performed and showed that the two populations 
clearly differed on the mRNA level. However, none of the genes analyzed presented with a 
substantially higher expression level to be considered a valuable adrenal stem cell marker 
candidate. 
Interestingly, the quantity of side population cells was significantly diminished in the 
context of Pbx1 haploinsufficiency. This transgenic mouse model is associated with smaller 
adrenal glands, a lower adrenal proliferation rate, and impaired adrenal function, suggesting a 
stem cell deficit in these animals. In contrast, Tpit-/- mice, which are ACTH-deficient, 
presented with a subcapsular zone width, which was significantly enlarged in comparison to 
wild type adrenals. Accordingly, the number of side population cells in these mice was 
significantly higher. ACTH treatment of these animals not only reverted the subcapsular zone 
width back to normal, but also resulted in a reduction of the side population fraction to a level 
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similar to that of wild type animals, providing indirect evidence for a stem cell ‘arrest’ in the 
state of ACTH deficiency. Overall, adrenal side population cells seem to be enriched with 
progenitor cells with a rather differentiated or designated phenotype. 
To define the characteristics of multipotent versus somatic adrenal stem cells, a fusion 
model was established. Herein, PEG mediated cell fusion between murine adult adrenal and 
embryonic stem cells was performed, however, did not render the expected spectrum of 
progenitor cells. 
The involvement of stem cell like cancer cells in adrenal tumorigenesis was assessed 
by identifying the side population in different human adrenal tumor entities and in the human 
adrenocortical carcinoma cell line NCI H295R. The latter were analyzed further and 
characterized, however, a tumor stem cell-like behavior could not be detected: NCI H295R 
side population cells had no greater contribution to tumor growth compared to the other cells 
and had no survival benefit upon exposure to chemotherapeutic substances, typically 
administered in this tumor entity. Therefore, identifying side population cells does not per se 
guarantee stemness, and should always result in further extensive investigations. 
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Zusammenfassung 
In Untersuchungen mit Hilfe radioaktiver- und transgener Tracer konnte gezeigt 
werden, dass die adulte Nebenniere einen subcapsulären Stammzellpool aufweist, der für die 
Organplastizität hauptsächlich verantwortlich zu sein scheint. Für Regenerations- und 
Anpassungsvorgänge migrieren Zellen aus dem subcapsulären Bereich ins Organinnere, wo 
sie innerhalb der verschiedenen spezialisierten adrenocorticalen Zonen differenzieren und 
endokrine Organfunktionen übernehmen. Die Isolierung und Charakterisierung der 
Nebennierenstammzelle ist allerdings bisher nicht gelungen, nicht zuletzt aufgrund fehlender 
bekannter Nebennierenstammzellmarker. Es kann angenommen werden, dass durch die 
Gewinnung der „Side Population“ (SP) aus Knochenmark und vielen anderen Geweben adulte 
Stammzellen angereichert werden können. Wegen fehlender Stammzellmarker passten wir die 
Methode an Nebennierenzellen an und konnten zeigen, dass SP-Zellen – im Gegensatz zu 
nicht-SP Zellen –über viele Passagen hinweg in vitro kultiviert werden konnten. In SP-
Zellkulturen konnte darüber hinaus nach 4 Wochen die Expression typischer Steroidenzyme 
immunhistologisch nachgewiesen werden, was auf eine spontane Differenzierung hindeutet. 
Auf der Suche nach weiteren, nebennierenspezifischeren Stammzellmarkern führten wir eine 
genomweite Microarray Analyse an SP und Nicht-SP-Zellen durch. Obwohl sich die beiden 
Populationen in Bezug auf ihr Expressionsmuster unterschieden, ließen sich keine Gene 
ermitteln, die als potentielle Nebennierenstammzellmarker in Frage gekommen wären. 
Transgene Mäusen, die haploinsuffizient für den Transkriptionsfaktor Pbx1 sind, 
zeichnen sich u.a. durch kleinere Nebennieren mit einer geringeren Proliferationsrate und 
beeinträchtigter Nebennierenrindenfunktion aus. Interessanterweise fand sich in diesen Tieren 
ein deutlich reduzierter adrenaler SP-Zell Anteil, so dass hier möglicherweise ein 
Stammzelldefizit vorliegen könnte. Bei ACTH-defizienten Tpit-/- Mäusen hingegen war die 
subcapsuläre Zone im Vergleich zu Wildtyptieren deutlich verbreitert. Passenderweise war 
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der Anteil der adrenalen SP-Zellen in diesem Fall deutlich erhöht. Eine ACTH-
Langzeittherapie der Tiere normalisierte nicht nur die Breite der subcapsulären Zone, sondern 
reduzierte auch die SP-Zellfraktion auf ein mit Wildtyptieren vergleichbares Niveau, was 
indirekt auf einen „Stamzellarrest“ in Tpit-/- Tieren hinweisen könnte. Aufgrund dieser Daten 
gehen wir zusammenfassend davon aus, dass es sich bei Nebennieren SP-Zellen am ehesten 
um schon recht differenzierte direkte oder designierte Vorläuferzellen handelt. 
Um somatische Progenitorzellen und multipotente Stammzellen in der Nebenniere 
identifizieren, unterscheiden und charakterisieren zu können, wurde ein komplexes PEG-
basiertes Fusionsmodell etabliert. Leider zeigten aber die resultierenden Zellen und 
Fusionshybride nicht das gewünschte Spektrum an unterschiedlich differenzierten 
Stammzellen. 
Des Weiteren wollten wir wissen, ob SP-Zellen als Tumorstammzellen in humanen 
Nebennierentumoren und der adrenocorticalen Zelllinie NCI H295R eine Rolle spielen 
könnten. Insbesondere die Zelllinie wurde detailliert untersucht, stammzellartige 
Eigenschaften konnten jedoch, trotz eindeutig identifizierbarer SP-Zellen, nicht gefunden 
werden: NCI H295R SP Zellen wuchsen nicht schneller und hatten, inkubiert mit diversen 
gebräuchlichen Chemotherapeutika, keinen Überlebensvorteil gegenüber Nicht-SP-Zellen. Es 
muss geschlussfolgert werden, dass der Nachweis von SP-Zellen das Vorhandensein von 
Stammzelleigenschaften nicht verlässlich vorhersagen kann und die isolierten Zellen stets 
einer genaueren funktionellen Untersuchung unterzogen werden müssen. 
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Introduction/Background 
Adrenal insufficiency and impaired steroidogenesis require life-long replacement 
therapies, and are associated with considerable morbidity [4,5]. Acute deficiency of 
glucocorticoids – ‘Addison crisis’ – is a common, dangerous threat for patients suffering from 
restricted adrenal function. Due to the rarity of the disease, those episodes often remain 
undiagnosed at first, leading to unnecessary and improper treatments, before the right 
diagnosis eventually is found. Furthermore, patients with adrenal insufficiency have a 
substantially lower quality of life compared to healthy controls [6]. For these patients, stem 
cell based treatments and replacement therapies should mean major advances. To achieve this 
goal, defining the adrenal stem cells, the stem cell niche and the regulatory mechanisms 
involved are prerequisites. 
As the structure of the adrenal gland divides the adrenal cortex in three distinct zones, 
and adaptive processes seem originate exclusively from a common pool of stem cells residing 
underneath the adrenal capsule, the adrenal gland is predestinated as a model to study stem 
cell regulatory and differentiation mechanisms. Furthermore, the adrenal gland is hormonally 
active and part of the hypothalamus-pituitary-adrenal axis, which easily allows monitoring of 
cell function by measuring hormone concentrations and their influence on the regulatory 
system. Studying the adrenal gland thus offers advantages over other organ systems in stem 
cell research field, despite the fact, that adrenal diseases are rare and research ambitions in 
this area are limited.  
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1. Embryonal development: 
 
During organogenesis, the adrenogenital primordium is formed, when coelomic 
epithelial cells migrate into the neighboring mesenchyme [7,8]. The adrenogenital 
primordium eventually separates, and the cranial migrating cells differentiate into adrenal 
precursor cells, forming the fetal zone of the adrenal cortex (human gestational week 4). Soon 
thereafter, cortisol production under ACTH regulation begins (human gestational week 8 – 9) 
[9]. The definitive zone of the adrenal cortex is build up, once mesothelium mesenchyme 
migrate into the mesenchyme and surround the forming cortex (human gestational week 22 – 
24) [10]. Temporarily, a third zone, called transitional zone, develops between the fetal and 
definitive zone after midgestation. Simultaneously, early cells of the sympathic nervous 
system, originating from the neural crest, migrate into the center of the developing adrenal 
gland where they differentiate into chromaffine adrenal medullary cells [11]. In the second 
trimester, the adrenal fetal zone makes up 80 – 90 % of the total adrenocortical cell mass, 
however vanishes quickly shortly after birth by differentiation and apoptosis. Zona 
glomerulosa and Zona fasciculata are now present, but the buildup of the Zona reticularis will 
take another 3 years of time. The zonation process of the adrenal cortex with its 3 distinct 
zones will not come to completion until shortly before puberty. It results in the well-known 
classical adrenocortical structure with an outer Zona glomerulosa, where mineralocorticoid 
production takes place, a Zona fasciculate with its glucocorticoid production, and the Zona 
reticularis with DHEA synthesis (Figure 1). 
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2.  Somatic stem cells 
 
Organ plasticity persists throughout life in the adrenal gland, necessary for adaption 
processes and organ maintenance. According to the ‘migration theory’ these tasks are 
believed to be carried by a somatic stem cell pool, which has its niche directly underneath the 
adrenal capsule (Figure 1). From here, the cells migrate radially towards the center of the 
adrenal gland and differentiate within the zone at need [3]. Somatic stem cells generally are 
believed to proliferate by symmetric and asymmetric cell division allowing the adjustment of 
the total number of persisting somatic stem cells as well as the number of differentiating cells 
(Figure 2A). 
 
Several observations support the migration theory concept: 
 In tritiated thymidine tracing studies, centripetal migration of adrenocortical 
cells from outer to inner layers was found[12]. 
 LacZ expression under a 21-hydroxylase[13] and a side chain cleavage 
enzyme promotor [14] in transgenic animals revealed a adrenocortical 
Figure 1 
Cross section of a 
murine adrenal gland, 
stained with H&E 
(100x magnification) 
depicting the specific 
adreno-cortical 




cells are believed to 
reside and from where 
migration towards the 
center for organ 
replenishment takes 
place. 
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staining pattern, suggesting that cells from inner adrenocortical zones 
originate from the subcapsular region, and that repopulation takes place in a 
‘radially variegated pattern’, as the cells in each ‘radial stripe’ have a 
common clonal origin. 
 The adrenocortical cortex reformed to some extend after enucleation of rat 
adrenals leaving behind the adrenal capsule only [15,16]. 
 unilateral adrenalectomy led to compensatory adrenal growth on the 
contralateral side [17]. Most of the proliferation activity was taking place 
within the subcapsular zone [2,18].  
 Stem cell typical signaling, such as active Wnt- and Shh- pathways, were 
virtually exclusively present in the subcapsular zone. When silenced, proper 
adrenal development was disrupted [19-21] 
 Genetically marked, originally subcapsular Gli1 positive cells, were found 
differentiated and steroidogenic enzyme expressing scattered throughout the 
adrenal cortex[20]. 
 
There is now evidence, that Gli1 positive, Sf1 negative cells might represent long-
lived non-steroidogenic adrenocortical subcapsular progenitor cells, while Gli1 positive, Sf1 
positive cells are more differentiated and centripetally displaced throughout the adrenal cortex 
[22]. 
Several marker genes could be identified for the definite zone (NovH, 
metallopanstimulin, CD56) and the fetal zone (P-Glycoprotein, low density lipoprotein (LDL) 
receptor) during embryogenesis [23,24], and, with limitations, for the Zona glomerulosa in the 
adult adrenal gland (Dab2, CD56) [25,26]. 
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Despite all these advances in adrenal developmental biology, the identification of 
adequate adrenal stem cell markers allowing the isolation or enrichment of adrenal stem cells 
for further in depth characterization had been unsuccessful thus far. As the fetal zone marker 
P-Glycoprotein is a product of the multidrug resistance gene 1, this finding helped to set base 
for the side population studies described below. 
 
3. Adrenal stem cell regulation 
 
Similar to marker genes, a few factors driving and regulating adrenal differentiation 
have been identified thus far. Besides its well accepted role as a regulator of P450 enzymes of 
steroidogenesis [27], the transcription factor and putative orphan nuclear receptor Sf1, was 
found mandatory for the initiation of the adrenal primordium and its further development, as 
Sf1 knock-out mice present with a complete agenesis of adrenal glands and gonads [28,29]. 
Dax1, another member of the orphan nuclear receptor superfamily, suppresses SF1mediated 
transactivation, however, shows a similar cellular distribution in highly proliferating areas of 
the adrenal cortex [30,31]. In humans, DAX1 dysfunction leads to X-linked adrenal 
hypoplasia [32,33]. Other transcription factors involved in adrenal development include pre-B 
cell leukemia transcription factor 1 (Pbx1) [34], Wilms tumor 1 (Wt1) [35,36], and 
CBP/p300-interacting transactivator with ED-rich tail 2 (Cited2) [36,37]. The latter acts as a 
Wt1 cofactor and boosters Sf1 transcription. Recently, the importance of secreted signaling 
mechanisms, such as the canonical Wnt [19,38] and Shh [20-22] signaling pathways, was 
described. In accordance with the orphan nuclear receptors, these factors are also 
indispensable for proper adrenal development (Table 1; for review: [39]).  
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Table 1: Overview of factors involved in adrenal development (adopted from Else et al.[45]) 
However, the individual roles of these factors for adrenal differentiation, or initiation 




human (mouse KO) 
Adrenal morphology 
human (mouse KO) 
Reference 
SF1 (Sf1) Transcription 
factor, NHR 
superfamily 
XY sex reversal 
(Lethal, gonadal aplasia 




adrenal hypoplasia (aplasia) 
[29,40-42] 
DAX1 (Dax1) Transcription 
factor, NHR 
superfamily 
XY sex reversal 
(Male infertility) 
Adrenal hypoplasia, 
persistence of fetal zone, 
adrenal insufficiency 









neural crest defects) 
(Adrenal aplasia) [37] 
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4.  The cancer stem cell concept 
 
It is intriguing to speculate that a small subset of cancerously transformed progenitor 
cells could be responsible for most of the tumor growth in a given tumor entity. As this 
progenitor could give rise to a variety of differentiated tumor daughter cells with diverse 
phenotypes, present therapeutic approaches aiming at tumor mass reduction to the greatest 
possible extent will fail to achieve long-term remissions, as residing malignant progenitors 
will eventually lead to recurrence of disease (Figure 2B). Furthermore, as progenitor cells 
seem to be equipped with cell membrane based pumps capable of cytotoxic drug exclusion, 
stem cell-like cancer cells are proposed to have the ability to withstand higher concentrations 
of cytotoxic agents used in standard chemotherapeutical regimens [46-48]. 
Besides a cancerously transformed progenitor cell, alternatively, a differentiated cell 
could regain stem cell characteristics with the same clinical and biological consequences [49]. 
This concept, which has first been established in hematological malignancies such as 
acute myeloid leukemia, was first described in solid breast cancer tumors by Al Hajj et al. 
Herein, CD44pos and CD24neg cells, which accounted for approximately only 0.1 % of the total 
tumor population, were able to regrow tumor in breast pads of SCID mice, while all other 
tumor cells transplanted in equal numbers on the contralateral side did not have that potential 
[50]. By now, tumor cells with stem-cell-like properties have now been described for a variety 
of solid tumors including, neuroblastomas [51], different brain tumors [52,53], head and neck 
squamous cell carcinomas [54], colon carcinomas [55], and pancreatic cancer [56]. 
Depending on the tumor type, different stem cell associated markers were utilized for the 
isolation of stem cell-like tumor cells. Common markers besides CD44/CD24 include CD133 
(prominin), c-kit, Sca-1, sphere forming ability and the side population phenomenon. 
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General accepted criteria for a stem cell-like cancer cell include [49,57-59]: 
 ability to self-renew 
 ability to re-grow the original tumor (e.g. in xenograft in vivo models) with 
 recapitulation of most or all more differentiated cell types within an individual 
tumor 
 extensive proliferative capacity 
 
Specifically targeting stem cell-like cancer cells could potentially eradicate the cellular 
origin of a stem cell driven tumor and cure the disease, even when the rest – in this case the 
majority – of tumor cells are left in place. This pathophysiological new concept has aroused 
considerable clinical interest. However, most isolation methods used today lead to cancer 
stem cell enriched heterogeneous and impure cell populations, limiting the advances in 
Figure 2: 
Stem cell concept: By symmetric cell division, a somatic stem cell can give rise to two daughter  
stem cells, or two differentiated cells. Alternatively, by assymetric cell division, a somatic stem cell 
can give rise to a stem cell and a differentiated cell (A). Cancer stem cell concept: Stem cell-like 
cancer cells, accounting for approximately 0.1 % of tumor cells, survive chemotherapy by drug 
evading mechanisms, eventually leading to recurrent disease (B). 
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specifically targeting stem cell-like cancer cells. However, even if this obstacle can be 
overcome, and a cancer stem cell treatment was found, it remains unclear what consequences 
such a treatment would mean for physiologic stem cells in other organ systems. 
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Own Contributions 
1. Adrenal side population enriches for adrenal progenitor cells [3] 
 
One approach for progenitor or stem cell enrichment is the side population isolation 
method. It is based on Hoechst 33342 dye exclusion mediated through cell membrane based 
pumps, resulting in a distinct small cell population stained less intense accounting for 
approximately 0.1 % of the total cell number ‘by the side’ upon FACS analysis with an 
ultraviolet laser [60,61]. The responsible membrane based pumps seem to be primarily 
encoded by the multidrug resistance genes Abcg2 and Mdr1, since suppression of these genes 
leads to fading or disappearance of the side population. Stem cells and premature cells are 
known to express multidrug resistance genes on their cell surface, allowing the side 
population phenomenon to be utilized for stem cell enrichment. This was tried first 
successfully with mouse bone marrow cells [61]. Later, based on this method, potential 
progenitors could successfully be isolated from multiple other tissues, including skin, muscle, 
liver, brain, lung, testes, endometrium, heart, and pituitary [62-71]. Several observations made 
investigating the side population in the adrenal gland particularly interesting: 
 Disruption of the sonic hedgehog pathway – which was found an important 
regulator of adrenocortical development – by cyclopamine, led to a significant 
reduction of side population cells [72] 
 Abcg2 has been proposed a regulator of sonic hedgehog signaling, [73] further 
indicating that cells isolated by Hoechst 33342 exclusion are involved in stem 
cell and progenitor cell signaling. 
 MDR1 was found to be a marker for the adrenal fetal zone 
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Hence, in the absence of adrenal stem cell markers, we adopted the side population 
protocol according to our needs to investigate the suitability of this procedure to enrich for 
murine adrenal progenitor cells. 
 
Side population cells could readily be detected in mouse adrenals and accounted for 
0.01 – 0.64 % of the total cell population (Figure 3A). As expected for a proposed cell 
population with stem cell like properties, side population cells continued to grow over 
multiple passages and over a period of several months, whereas non-side population cells 
exposed to the same culture conditions adhered to the culture plate but never grew to a 
Figure 3 (adopted from [3]):  
FACS staining pattern and gating of SP and non-SP (NSP) cells (A). Morphological appearance of 
SP and NSP cells cultured for 7 days (B). FACS reanalysis of cultured side population cells (C). 
Immunohistochemistry of long-term cultured SP cells revealed the expression of the steroidogenic 
enzymes 3beta-Hydroxysteroid-dehydrogenase (3ß-HSD), p450 side chain cleavage enzyme 
(SCC), and steroidogenic acute regulatory protein (StAR) (D) 
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relevant density. Consistently, passaging of non-side population cells was not possible, 
demonstrating self-renewal and proliferative capacity for murine adrenal side population cells 
only (Figure 3B). Re-staining with Hoechst 33342 dye and Re-FACS analysis of long-term 
cultured side population cells resulted – except for an expected higher proportion of side 
population cells – in a FACS pattern similar to the original FACS sort, suggesting asymmetric 
cell division (Figure 3C). 
Immunohistochemistry of long-term cultured side population cells grown on cover 
slips in a standard adrenal culture medium revealed the expression of a variety of 
adrenocortical markers and typical steroidogenic enzymes indicating spontaneous 
differentiation in vitro (Figure 3D). We were not able to detect significant amounts of 
glucocorticoid concentrations in the culture medium, an observation we routinely find in 
adrenal primary cultures grown in vitro for a couple of weeks. Besides this exception, the 
established stem cell characteristics self-renewal, asymmetric cell division and differentiation 
were met by murine adrenal side population cells. 
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2. Potential regulators of the adrenal side population [3] 
 
For studying potential regulators of adrenal side population cells, we took advantage 
of two available transgenic mouse models. 
Pbx1 is an important transcription factor for proper adrenal development, maybe even 
with a regulatory function upstream of Sf1. Both factors seem to work synergistically. 
Homozygous knock-out of Pbx1 leads to bilateral adrenal aplasia and is lethal. Adrenals in the 
context of Pbx1 haploinsufficiency are smaller in size, present with a lower proliferation rate 
(Figure 4), and impaired adrenal function, demonstrated by higher basal ACTH levels and 
lower glucocorticoid output upon restrained stress experiments [2].  
 
 
When Pbx1+/- adrenals were stained with Hoechst 33342 dye and FACS analyzed 
using our standardized protocol and machine settings, the number of SP cells in Pbx1 
haploinsufficient animals was significantly smaller compared to wild type adrenals, possibly 
indication a stem cell deficit in these animals (Figure 5) 
 
Figure 4 (adopted from [2]): 
Adrenals from Pbx haploinsufficient animals are smaller in size with lower adrenal weight (A), and a 
lower proliferation index indicated by less PCNA expression on the mRNA (B) and protein level 
(C). IHC reveals that most of the proliferation occurs in the subcapsular zone (C) 
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In contrast to this observation, Tpit-/- mice present with an adrenal subcapsular zone 
which is substantially thinker compared to wild type animals. These mice are ACTH-deficient 
and the wider adrenal subcapsular zone is similar to that of ACTH receptor knock-out mice 
[74], strongly indication that disrupted ACTH signaling leads to those morphological changes.  
 
As described typical for the subcapsular zone, and in contrast to the rest of the adrenal 
cortex, the enlarged subcapsular region of Tpit-/- animals did not stain positive for 
steroidogenic enzymes upon immunohistochemistry, which is in accordance with the theory 
of a residing stem cell pool in the periphery of the adrenal cortex. Interestingly, the larger 
subcapsular zone coincides with a significant higher amount of side population cells in these 
Figure 5 (adopted from[3]): 
H&E staining of wild type 
and haploinsufficient Pbx1 
mice, characterized by 
smaller adrenal glands with a 
thinner adrenal cortex 
(100x magnification, A). 
Corresponding FACS sort 
gating and –count of side 
population cells of Pbx+/- 
animals, displaying a 
diminished number of side 
population cells in the context 
of Pbx1 haploinsufficiency 
(B). Quantification of the 
total number of side 
population cells of Pbx1+/+ 
versus Pbx+/- animals (C).
*= p < 0.01 
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adrenals compared to wild type adrenals. Furthermore, ACTH application in vivo over 7 days 
not only reverted the zone width back to normal, but is paralleled by a normalization of the 
number of side population cells in these animals (Figure 6). These data might indicate a ‘stem 
cell arrest’ with impaired differentiation capabilities in the context of ACTH deficiency.  
 
Keeping this interpretation in mind, the higher ACTH levels detected in Pbx1 
haploinsufficient animals could have driven a higher amount of subcapsular adrenal 
progenitor cells towards differentiation, reducing the number of dormant progenitors in the 
subcapsular zone. In conclusion, ACTH has to be considered an important regulator of 
Figure 6 (adopted from[3]): 
Subcapsular zone width (S) is thicker in Tpit KO mice (H&E staining A/B; 3ßHSD staining A/E) 
compared to heterozygous animals (A/A and A/D), but reverts back to normal after ACTH 
treatment (A/C and A/F). Likewise, the side population fraction is higher compared to normal 
controls and normalizes after ACTH treatment (B). Quantification of the number of side population 
cells measurable in Tpit+/- mice compared to Tipt-/- mice and long-term ACTH treated Tpit-/- 
animals (C). 
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adrenocortical stem cell maintenance and fate in addition to its well defined action on 
steroidogenesis.  
As the ability to exclude Hoechst 33342 dye is not exclusively found in progenitor 
cells, the side population has to be regarded as a heterogeneous collection of cells. Although 
enriching progenitor cells is possible, side population cells cannot compensate for adequate 
adrenal specific stem cell markers. Therefore, whole genome microarray analysis was 
performed on side population versus non-side population cells to elucidate relevant gene 
expression differences between the two cell types. Since the number of harvestable adrenal 
side population cells per mouse is limited, microarray analysis was performed on a platform 
optimized for small cell numbers [75]. Expectedly, the expression patterns of the two 
populations clearly differed. Genes associated with stem cell signaling tended to be higher 
expressed, while Sf1 tended to be lower expressed in side population cells. However relevant 
divergence could only be found for sets of genes and not for individual genes. Unfortunately, 
even within the gene sets, no interesting candidates for a potential stem cell marker could be 
identified [3]. 
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3.  Defining pluripotent and committed adrenal stem cells 
 
Since microarray analysis did not reveal relevant adrenal stem cell markers, alternative 
strategies were being sought. Starting in the late 1990’s, fusion of somatic cells or somatic 
stem cells with embryonic stem (ES) cells of both mouse and human origin arouse great 
attention, as fusion hybrids were found to be pluripotent [76,77]. It has been proposed that the 
somatic fusion partner undergoes reprogramming during the fusion process, in that regulatory 
programs of gene expression change along with alterations of DNA methylation, leading to a 
dedifferentiation of the somatic cell towards a lesser differentiated state. Do et al. even 
demonstrated a complete erasure of the ‘somatic memory’ of adult neurospheres upon cell 
fusion [78]. In consequence, fusion hybrids were found to have an epigenetic status and 
phenotype similar to that of embryonic stem cells: Genes associated with pluripotency were 
hypomethylated, the hybrid cells displayed prolonged self-renewal ability, differentiated into 
derivatives of the three germ layers and even contributed to chimeras [79,80]. Despite these 
conformities with embryonic stem cells, fusion hybrids usually remain tetra- or polyploid, 
although spontaneous reduction to regular diploidity has been observed [81]. However, this 
reduction process is considered a very rare event. Furthermore, expression profiling led to the 
notion that fusion hybrids remain cells with features distinct different from both of the 
originating cell populations [82]. Similarly, later studies demonstrated, that cell fusion does 
not inevitably mean a unidirectional dedifferentiation process, but that, depending on the 
experimental settings, characteristics of the somatic fusion partner can be acquired by fusion 
hybrids during the fusion process as well [83-85].  
In consequence, cell fusion appeared to be an ideal method to achieve a whole 
spectrum of different adrenal cell types, ranging from pluripotent, more embryonic cells to 
dedicated somatic adrenal progenitors. Serving as a model for adrenal cells in various 
differentiation stages, we postulated that in depth characterization of fluorescence labeled 
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resulting fusion hybrids, clonally expanded, should allow the identification of genes, relevant 
for governing adrenal precursors or regulating differentiation.  
We adopted the well-established polyethylenglycol (PEG) mediated cell fusion 
method in our laboratory. In our model, adult adrenocortical cells from green-fluorescence-
protein (GFP)-labeled Oct4 mice (fluorescence not expressed) were fused with embryonic 
stem cells from td(red fluorescence protein)RFP-labeled SF1 mice (fluorescence not 
expressed). While the adult adrenal cells were obtained by applying a single cell suspension 
protocol well established in our laboratory, the embryonic stem cells were harvested from 
embryonic primary cultures from crossbred SF1-Cre and tdRFP reporter mice (Figure 7). 
 
 
Figure 7:  
Fusion project outline resulting in Sf1 dependent td-RFP expression and Oct4 dependent GFP 
expression. Fusion of SF1-td-RFP blastocysts with Oct4-GFP adrenal cells should result in a variety 
of tetraploid fusion hybrids (B). As controls, Sf1-td-RFP adult adrenal cross sections display red 
fluorescence (A). Oct4-GFP blastocysts display green fluorescence. 
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Fusion hybrids should either express green fluorescence, once Oct4 transcription is 
activated and the cell was reprogrammed to a rather embryonic state, or should express red 
fluorescence, if SF1 is expressed, an essential step for initiating differentiation towards the 
steroidogenic lineage. Alternatively, both fluorescences could become induced in cells with 
intermediate phenotypes. If no fusion has taken place, no fluorescence is detectable as neither 
the adult Oct-4/GFP adrenal cells nor the embryonic SF-1/tdRFP cells will have the ability to 
induce expression of the transgenes. According to the expertise of Hans Schöler’s laboratory 
at the Max Planck Institute in Münster, GFP positive reprogrammed cells can be expected 
approximately 2 – 3 days after cell fusion [83]. However, out of 10 highly technically 
demanding cell fusion experiments, we were able to detect dim tdRFP expression only in one 
culture dish after 14 days, indicating differentiation towards the steroidogenic lineage. 
Figure 8: 
Tetraploid cells in small numbers were found in td-RFP negative cell populations only. 
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Prolonged culturing intensified the detectable fluorescence over time. Surprisingly, 
tetraploidity was found in 2 % of cells in the fluorescence negative control group only (Figure 
8).  
Embryonic bodies are routinely used as a model for unspecific spontaneous 
differentiation of embryonic stem cells. Embryonic bodies derived from Sf1-tdRFP 
embryonic stem cells revealed increasing fluorescence intensity over time. Accordingly, Sf1 
mRNA expression significantly increased in accordance to tdRFP fluorescence intensity 
(Figure 9).  
Taken together, the fusion project did not render the desired spectrum of progenitor 
fusion hybrids. In contrast to the findings described in the literature, reprogrammed cells 
could not be detected. Technical and procedural difficulties have been tried to overcome by 
carrying out the fusion experiments partially in the Max Planck Institute for Developmental 
Biology in Münster, where a research group routinely fuses embryonic stem cells with neural 
progenitor cells. Even in their hands, better results were not obtainable, possibly because the 
fluorescence model is not working as it should, or because the cells used are not suitable for 
cell fusion experiments. Whatsoever, as the Sf1-tdRFP construct reliably turned red upon 
differentiation, this construct appears to be valuable to be utilized in other differentiation 
studies. 
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Figure 9:  
Prolonged cultivation of dim td-RFP positive cells resulted in an increase of fluorescence intensity 
and Sf1 expression on the mRNA level after multiple passages, while cells without fluorescence 
after 14 days of culturing remained td-RPF negative (A). Formation of embryonic bodies results in 
detectable red fluorescence and Sf1 upregulation, suggesting spontaneous, undirected 
differentiation towards the steroidogenic lineage. 
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4.  Stem cell-like tumor cells in adrenocortical carcinomas [1] 
 
Adrenocortical carcinomas are rare, but highly malignant tumors of the adrenal cortex, 
which respond poorly to standard chemotherapeutic substances [86]. Cellular heterogeneity of 
the tumor and the presence of multi-drug resistance genes, which encode for membrane based 
pumps that actively expel the cytotoxic drugs are being discussed as two underlying 
mechanisms for this clinical observation [87]. P-glycoprotein was found a marker for the 
adrenal definitive zone [24] and represents a prototype member of the ATP-binding cassette 
(ABC) transporter family – especially Multi-Drug-Resistance-Gene 1 (MDR1) [61] and 
Breast Cancer Resistance Gene 1 (ABCG2) [60], which are ATP-dependent membrane 
proteins predominantly expressed in excretory organs. Since the Hoechst efflux capacity of 
side population cells is based on these pumps [88], the identification of the side population in 
adrenocortical tumors should allow an enrichment of stem cell-like tumor cells and thus the 
study of relevance of these cells in adrenocortical malignancies 
The side population was first described for the isolation and characterization of stem 
cell-like cancer cells in neuroblastoma tumors and corresponding cell lines by Hirschmann-
Jax et al [51]. Herein, similar to stem cell-like tumor cells isolated on the basis of cell surface 
markers, side population tumor cells were found to proliferate, self-renew, and withstand 
chemotherapy substances better than non-side population cells. Later, studies have extended 
these findings to primary cultures for example of gastrointestinal cancers [89,90], and ovarian 
cancer [91]. Interestingly, besides neuroblastoma cell lines, the isolation of tumor-like stem 
cells based on the Hoechst 33342 (side population) exclusion method could also be 
demonstrated for a variety of other tumor cell lines such as glioma [92], breast [93], thyroid 
cancer [94], and melanoma [95] cell lines. This is remarkable, keeping in mind that cell lines 
are believed to be prototypes for monoclonal cell expansion. 
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After optimizing the protocol for adrenal tumor primary cultures, we could 
demonstrate the presence of side population cells in a variety of different human adrenal 
tissues including adrenocortical carcinomas, adenomas with different clinically relevant 
hormonal excesses, and different human and mouse adrenocortical carcinoma cell lines. The 
side population fraction tended to be larger the more aggressive the tumor entity was. For in 
depth analyses and in order to obtain comparable results, we decided to thoroughly investigate 
the well-established and widely used adrenocortical cancer cell line NCI H295R [96,97], as 
the obtainable number of fresh adrenal cancers is very limited due to the rarity of the disease. 
In contrast to our previous observations with regular adrenal side population cells and 
in contrast to the findings published by other groups, non-side population cells from NCI 
H295R cells proliferated at a similar rate as side population cells when co-cultured in equal 
cell numbers (Figure 10). 
 
Figure 10 (adopted from [1]): 
Side population (SP) and non-side population cells (NSP) had the same proliferation rate (A). To 
exclude contamination, SP and NSP cells were stained with different colours and cultured together. 
Still, SP cells had no proliferation advantage over NSP cells (B). 
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 Interestingly, although – as expected – the fraction of side population cells was higher 
in FACS re-sorted side population cultures, side populations could consistently be detected in 
cultured non-side population cells as well, which is incompatible with the side population 
stem cell theory (Figure 11).  
 
This finding was surprising, especially since great care was taken to ensure that all 
established criteria to identify a valid side population were fulfilled: 
 Disappearance of the side population upon FACS analysis after pre-incubation 
with the calcium channel blocker verapamil 
 Optimization of the Hoechst 33342 staining procedure by confocal laser 
microscopy and FACS time course experiments 
 
Figure 11 (adopted from [1]): 
In resorting experiments, SP cells (in %) could readily be detected in original side population and 
non-side population (NSP) cultures.  
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 Lower staining intensity of side population cells compared to non-side 
population cells was verified using confocal laser microscopy. Accordingly, 
MDR1 and ABCG2 were significantly higher expressed on the mRNA level in 
side population cells 
 For comparative experiments, side populations cells from the outer tip of the 
side population fraction were utilized only, to ensure the highest purity of side 
population cells possible [98,99] 
 Compared to non-side population cells, side population cells expressed genes 
responsible for steroidogenesis on a significantly lower level in accordance 
with the presumed more undifferentiated state. 
 
Possible explanations for the same proliferation rate of side population and non-side 
population cultures include cell cycle dependent expression or activity of the membrane based 
pumps, or epithelial mesenchymal transition. Cell cycle differences between the two 
populations could not be found. Epithelial-mesenchymal transition is generally accepted as an 
important mechanism for tumor infiltration and metastasis. Although the original model 
proposes a unidirectional change towards a lesser differentiated mesenchymal phenotype, 
there is evidence suggesting the presence of incomplete epithelial-mesenchymal transition as 
well as a reversion of this transition [100]. However, differences in epithelial or mesenchymal 
marker expression levels between side population and non-side population cells could not be 
found. Clinically most relevant for stem cell-like tumor cells is certainly their ability to 
discharge or repel cytotoxic substances by membrane based pumps. As expected, we found 
ABCG2 and MDR1, the genes encoding for these pumps, substantially higher expressed in 
NCI H295R side population cells. Despite this equipment, with the exception of a mild effect 
in an etoposide environment, a relevant overall survival benefit compared to non-side 
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population cells could not be observed (Figure 12). 
 
 
Since MTT measurements were performed, we cannot rule out that a small number of 
cells with stem cell characteristics in the side population dishes would have survived 
prolonged culturing.  
 
In summary, side population cells of NCI H295R cells were indistinguishable in terms 
of viability, cell proliferation and cytotoxic resistance from non-side population cells, 

























































































































Figure 12 (adopted from [1]): 
Side population cells (white columns) - 
with the exception of a mild effect when 
exposed to etoposide (*=p<0.05) - did 
not have a general survival advantage 
over non-side population cells (black 
columns), when being co-incubated with 
chemotherapeutic agents routinely used 
for adrenocortical carcinomas. 
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whether these findings are attributed to this particular cell line, or if side population cells do 
not play a relevant pathophysiological role in adrenocortical carcinomas.  
 
Nevertheless, this study arrestingly demonstrates that the mere identification of side 
population cells, even when all selection criteria were stringently fulfilled, does not guarantee 
‘stemness’ per se. These cells need to be further evaluated and characterized functionally, to 
validate presumed progenitor capabilities. 
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Summary & Outlook 
Despite the advances in stem cell biology, the endocrine stem cell field is still 
evolving, and besides the fact, that somatic stem cells seem to persist throughout life in the 
endocrine system, little is known about their nature and the niche in which they reside. The 
extent of plasticity of these cells and the mechanisms of their differentiation are uncertain, 
although some important factors have now been described. One of the reasons for the slow 
progress in adrenal stem cell research can be attributed to the rarity of adrenal diseases and 
the lack of appropriate tissue material. Nevertheless, it is generally accepted that current 
treatment regimens, no matter if substitution of adrenal insufficiency or adrenal cancer 
therapies, are insufficient for affected patients. This is the driving force to continue with 
adrenal stem cell research beside the goal to improve and extent the knowledge of physiology 
and mechanisms and factors in this field. 
Applying the side population technique is an interesting approach to enrich progenitor 
cells, especially in the absence of well characterized marker genes. Earlier published 
observations on how adrenocortical cells are equipped together with the proposed mechanism 
of the side population phenomenon, made this approach the first choice to study. Expectedly, 
adrenal side population cells could be isolated, which fulfilled the general stem cell criteria 
self-renewal, proliferation and differentiation. Unfortunately, further investigations including 
whole genome microarray analysis, did not result in the detection of more adrenal specific 
stem cell markers. Our study however demonstrated regulatory effects for the transcription 
factor Pbx1 and for ACTH on side population cells, and therefore presumably also for adrenal 
progenitors.  
Defining one or several tissue specific stem cell markers is a prerequisite for 
substantiated stem cell research. The fusion project was another approach to achieve this goal. 
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PEG-mediated cell fusion was applied to generate different types of progenitor cells ranging 
from embryonic-like pluripotent cells to designated adrenal progenitors. Unfortunately, 
despite several approaches, the desired fusion hybrids could not be obtained. As tetraploidity 
is inevitable, fusion hybrids would be an inferior choice for cell replacement treatment 
strategies. After all, continuing this project would have been unreasonable. Nevertheless, the 
project allowed the establishment of embryonic stem cell techniques in our lab und bore Sf1-
tdRFP cells, which can be utilized as differentiation markers for further studies. 
While the fusion project was underway, Yamanaka’s land-mark paper was published, 
allowing cellular reprogramming back to the embryonic stage by applying 4 key factors, Oct4, 
Sox2, c-Myc, and Klf4, resulting in so called induced pluripotent stem cells [101]. Although 
this method is slower and not more efficient than stem cell fusion, resulting cells are more 
homogeneous and have regular ploidity [83]. Although not yet published, there is little doubt 
that reprogramming adrenal cells is possible, when this or other reprogramming protocols are 
applied. Recently, induced pluripotent stem cells could be transformed or differentiated to 
some extend into steroid producing cells by virally transfecting Sf1 [102]. Even so, we are not 
pursuing projects involving induced pluripotent stem cells as major obstacles of modern 
embryonic stem cell research, such as the dependence on viral vectors for efficient 
reprogramming, teratoma formation, or incomplete differentiation have yet to be overcome. 
A more promising strategy in this context could be a limited reprogramming towards a 
designated progenitor, instead of reprogramming the cells completely towards the embryonic 
stem cell state. This more direct route has now been described for hepatocytes [103,104], 
cardiomyocytes [105], and neurons [106]. Newer data even suggests, that, in contrast to 
transdifferentation, a conversion of differentiated cells into a desired target tissue via 
designated progenitors by reprogramming could be possible in vivo. In this study, exocrine 
pancreatic cells were converted into functional ß-cells [107]. Although this concept could be 
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adapted to our needs by e.g. co-transfecting Sf1 and Oct4, there is no way around clearly 
defining and characterizing the adrenal somatic stem cell. 
Recently, sonic hedgehog signaling studies on murine adrenal glands has led to the 
notion, that adrenal progenitor cells in the subcapsular region could be divided into long-term 
and short-term progenitor cells, defined as Sf1pos and Gli1pos cells being long-term, and Sf1pos 
Gli1neg cells being short term progenitors. Although these markers are not suitable for cell 
isolation, this study means a step forward in understanding and defining the adrenal stem cell. 
It would be e.g. interesting to see, if Gli1 or Ptch are significantly expressed in adrenal side 
population cells. 
Although the initial enthusiasm regarding stem cell like-cancer cells seems to fade, 
this theory has become an accepted concept in modern tumor pathophysiology. The relevance 
and the extent of these subpopulations of tumor cells in endocrine cancer entities have yet to 
be clarified. We addressed this issue by characterizing the side population, which could be 
reliably detected in numerous human adrenal tumor entities and in the cell line NCI H295R. 
We could exclude that side population cells play a relevant role as ‘cancer stem cells’ in this 
standard model for adrenocortical cancer. This project in addition impressively demonstrated 
that one has to be cautious declaring a certain cell type as stem cells utilizing an established 
stem cell isolation method, without further characterizing these cells. 
After all, the projects certainly not always rendered the anticipated results, and 
cleaving to the projects, trying to find the reasons and mechanisms for divergent data, was a 
challenge. Nonetheless, it has been great pleasure to work for several years intensively in the 
field of endocrinology, where stem cell research has been just emerging. A whole variety of 
topics and lab techniques from embryonic stem cells to stem cell-like cancer cells were 
covered. One of our ongoing projects focuses on the screening of different types of 
pheochromocytomas and paragangliomas for the expression of a variety of typical stem cell 
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markers. Tissue-array analyses on several hundred samples collected Europe-wide should 
allow to reliably answer the question whether and which stem cell markers are significantly 
expressed on the protein level in this tumor entity. Further studies will aim to investigate their 
involvement in tumorigenesis.  
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chromosome X, gene 1 
CD24   heat stable antigen CD24 (HSA) 
CD44   cell-surface glycoprotein 
CD56   neural cell adhesion molecule (NCAM) 
DHEA   dehydroepiandrosteron 
GFP   green fluorescence protein 
Gli1   Gli family zinc finger 1 
LacZ   gene encoding β-galactosidase 
MDR1/ABCB1  multidrug resistance 1, P-glycoprotein 1 
Oct4   octamer binding transcription factor 4 
Pbx1   pre-B-cell leukemia transcription factor 1 
Ptch1   protein patched homolog 1 
Sca-1   stem cell antigen-1 
SCID   severe combined immunodeficiency 
Sf1   steroidogenic factor 1 
Shh   sonic hedgehog 
tdRFP   tandem-dimer red fluorescent protein 
Tpit   T-box factor, TPX19 
Wnt   family of highly conserved secreted signaling molecules 
X-zone develops in the inner adrenal cortex of mice; similar to fetal zone in 
primates 
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